Animation in Direct-to-Consumer Advertising

Forms and Documents

Document Name	Status
Animation OMB Supporting Statement PART B.pdf Supporting Statement B	2016-10-25
Animation OMB Supporting Statement PART A.pdf Supporting Statement A	2016-10-25

IC Document Collections

IC ID	Document Title	Status
224140	MAIN Study: No. of completes Other-Screener and Questionnaire	New
224139	MAIN Study: No. to complete screener (assumes 50% eligible) Other-Study Consent Form	New
224138	PREtesting: No. of completes Other-Study and Questionnaire	New
224137	PREtesting: No. to complete screener (assumes 50% eligible) Other-Study Consent Form	New

ICR Details

OMB Control No: 0910-0826	ICR Reference No: 201610-0910-009
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: HHS/FDA	Agency Tracking No: CDER
Title: Animation in Direct-to-Consumer Advertising
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 12/06/2016
	Date Received in OIRA: 10/26/2016
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	12/31/2019	36 Months From Approved
Responses	5,940	0	0
Time Burden (Hours)	1,149	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: This information collection supports an agency study regarding how animation affects attitudes toward products and risk perceptions in drug ads; and studies how various animation strategies (e.g., symbolizing the disease vs. the benefit) and product characteristics (e.g., low-risk -medication vs. high-risk medication) influence these perceptions.

---

Authorizing Statute(s): US Code: 21 USC 393(b)(2)(c) Name of Law: FD&C Act; Promoting the public health
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	81 FR 10867	03/02/2016
30-day Notice:	Federal Register Citation:	Citation Date:
	81 FR 73410	10/25/2016
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 4

IC Title	Form No.	Form Name
PREtesting: No. to complete screener (assumes 50% eligible)
MAIN Study: No. to complete screener (assumes 50% eligible)
PREtesting: No. of completes
MAIN Study: No. of completes

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	5,940	0	0	5,940	0	0
Annual Time Burden (Hours)	1,149	0	0	1,149	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: This is a new information collection in support of an agency study.

---

Annual Cost to Federal Government: $185,955

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 10/26/2016

---